Background: Poorly differentiated carcinoma (PDC) of the thyroid includes tall and columnar cell variants
. 1 . A, Disease-specific survival distribution based on Kaplan-Meir product-limit estimate according to the presence of distant metastasis. There was good disease-specific survival in the patients with no metastasis of thyroid cancer (P < 0.001). B, Disease-specific survival distribution based on Kaplan-Meir product-limit estimate according to the radioactive iodine therapy There was good disease-specific survival in the patients with postoperative radioactive iodine therapy group (P = 0.047). 이상으로 정의하였으나, 실제로 대부분의 경우 75% 이상의 Fig. 3 . Disease-specific survival distribution based on Kaplan-Meir product-limit estimate according to pathologicTumor-Node-Metastasis (pTNM) stage. There were statistically significant difference in TNM stage I versus II (P = 0.0072) and TNM stage I versus IV (P = 0.0006). The significance levels were adjusted by using Bonferroni's correction to eliminate chance associations. Fig. 2 . A, Disease-specific survival distribution based on Kaplan-Meir product-limit estimate according to the patients with thyroid carcinoma with insular, trabecular and solid growth patterns and the patients with aggressive variants of papillary carcinoma, There were no statistical differences between insular, trabecular and solid types of the poorly differentiated carcinoma (n = 46) and tall cell and columnar cell variants of the papillary carcinoma (n = 14, P = 0.51). B, Disease-specific survival distribution based on Kaplan-Meir product-limit estimate according to the patients with diagnosed as poorly differentiated carcinoma (PDC) after thyroidectomy for well-differentiated carcinoma (WDC). There was significant difference between the patients with primarily diagnosed as PDC of the thyroid and the patients with diagnosed as PDC after thyroidectomy for WDC of the thyroid (n = 10, P = 0.0175). 
